136 related articles for article (PubMed ID: 33059348)
1. Persistent Interferon Production by Double Negative T Cells and Collapsing Focal Segmental Glomerulosclerosis.
Lohani S; Sadasivam M; Rabb H; Atta MG
Nephron; 2021; 145(1):85-90. PubMed ID: 33059348
[TBL] [Abstract][Full Text] [Related]
2. Collapsing glomerulopathy associated with natural killer cell leukemia: a case report and review of the literature.
Palma Diaz MF; Pichler RH; Nicosia RF; Alpers CE; Smith KD
Am J Kidney Dis; 2011 Nov; 58(5):855-9. PubMed ID: 21908087
[TBL] [Abstract][Full Text] [Related]
3. APOL1-Associated Collapsing Focal Segmental Glomerulosclerosis in a Patient With Stimulator of Interferon Genes (STING)-Associated Vasculopathy With Onset in Infancy (SAVI).
Abid Q; Best Rocha A; Larsen CP; Schulert G; Marsh R; Yasin S; Patty-Resk C; Valentini RP; Adams M; Baracco R
Am J Kidney Dis; 2020 Feb; 75(2):287-290. PubMed ID: 31601430
[TBL] [Abstract][Full Text] [Related]
4. Collapsing glomerulopathy: a clinically and pathologically distinct variant of focal segmental glomerulosclerosis.
Detwiler RK; Falk RJ; Hogan SL; Jennette JC
Kidney Int; 1994 May; 45(5):1416-24. PubMed ID: 8072254
[TBL] [Abstract][Full Text] [Related]
5. Cytomegalovirus-induced collapsing focal segmental glomerulosclerosis.
Grover V; Gaiki MR; DeVita MV; Schwimmer JA
Clin Kidney J; 2013 Feb; 6(1):71-73. PubMed ID: 27818753
[TBL] [Abstract][Full Text] [Related]
6. CD44 is required for the pathogenesis of experimental crescentic glomerulonephritis and collapsing focal segmental glomerulosclerosis.
Eymael J; Sharma S; Loeven MA; Wetzels JF; Mooren F; Florquin S; Deegens JK; Willemsen BK; Sharma V; van Kuppevelt TH; Bakker MA; Ostendorf T; Moeller MJ; Dijkman HB; Smeets B; van der Vlag J
Kidney Int; 2018 Mar; 93(3):626-642. PubMed ID: 29276101
[TBL] [Abstract][Full Text] [Related]
7. Collapsing glomerulopathy.
Schwimmer JA; Markowitz GS; Valeri A; Appel GB
Semin Nephrol; 2003 Mar; 23(2):209-18. PubMed ID: 12704581
[TBL] [Abstract][Full Text] [Related]
8. [Collapsing focal segmental glomerulosclerosis induced by cytomegalovirus: A case report].
Grèze C; Garrouste C; Kemeny JL; Philipponnet C; Aniort J; Heng AÉ
Nephrol Ther; 2018 Feb; 14(1):50-53. PubMed ID: 29191574
[TBL] [Abstract][Full Text] [Related]
9. Abnormally differentiated CD4+ or CD8+ T cells with phenotypic and genetic features of double negative T cells in human Fas deficiency.
Rensing-Ehl A; Völkl S; Speckmann C; Lorenz MR; Ritter J; Janda A; Abinun M; Pircher H; Bengsch B; Thimme R; Fuchs I; Ammann S; Allgäuer A; Kentouche K; Cant A; Hambleton S; Bettoni da Cunha C; Huetker S; Kühnle I; Pekrun A; Seidel MG; Hummel M; Mackensen A; Schwarz K; Ehl S
Blood; 2014 Aug; 124(6):851-60. PubMed ID: 24894771
[TBL] [Abstract][Full Text] [Related]
10. Collapsing glomerulopathy: clinical characteristics and follow-up.
Grcevska L; Polenakovik M
Am J Kidney Dis; 1999 Apr; 33(4):652-7. PubMed ID: 10196005
[TBL] [Abstract][Full Text] [Related]
11. COVID-19-Related Glomerulopathy: A Report of 2 Cases of Collapsing Focal Segmental Glomerulosclerosis.
Magoon S; Bichu P; Malhotra V; Alhashimi F; Hu Y; Khanna S; Berhanu K
Kidney Med; 2020; 2(4):488-492. PubMed ID: 32775989
[TBL] [Abstract][Full Text] [Related]
12. Dysregulation of podocyte phenotype in idiopathic collapsing glomerulopathy and HIV-associated nephropathy.
Yang Y; Gubler MC; Beaufils H
Nephron; 2002 Jul; 91(3):416-23. PubMed ID: 12119471
[TBL] [Abstract][Full Text] [Related]
13. Immunity unmasks APOL1 in collapsing glomerulopathy.
McNicholas BA; Nelson PJ
Kidney Int; 2015 Feb; 87(2):270-2. PubMed ID: 25635718
[TBL] [Abstract][Full Text] [Related]
14. Collapsing glomerulopathy in sickle cell disease: a case report.
Ramidi GB; Kurukumbi MK; Sealy PL
J Med Case Rep; 2011 Feb; 5():71. PubMed ID: 21338490
[TBL] [Abstract][Full Text] [Related]
15. COVID-19-Associated Collapsing Focal Segmental Glomerulosclerosis: A Report of 2 Cases.
Sharma Y; Nasr SH; Larsen CP; Kemper A; Ormsby AH; Williamson SR
Kidney Med; 2020; 2(4):493-497. PubMed ID: 32775990
[TBL] [Abstract][Full Text] [Related]
16. Remission of collapsing focal segmental glomerulosclerosis following chemotherapy for myeloma.
Shah S; Cavenagh J; Sheaf M; Thuraisingham RC
Am J Kidney Dis; 2004 Feb; 43(2):e10-2. PubMed ID: 14750118
[TBL] [Abstract][Full Text] [Related]
17. [Collapsing variant of focal segmental glomerulosclerosis by parvovirus B19: case report].
Freitas GR; Praxedes MR; Malheiros D; Testagrossa L; Dias CB; Woronik V
J Bras Nefrol; 2015; 37(1):121-6. PubMed ID: 25923759
[TBL] [Abstract][Full Text] [Related]
18. Modulation of podocyte phenotype in collapsing glomerulopathies.
Barisoni L; Kopp JB
Microsc Res Tech; 2002 May; 57(4):254-62. PubMed ID: 12012394
[TBL] [Abstract][Full Text] [Related]
19. De novo CMV-associated collapsing focal segmental glomerulosclerosis in a kidney transplant recipient.
Patel AM; Zenenberg RD; Goldberg RJ
Transpl Infect Dis; 2018 Jun; 20(3):e12884. PubMed ID: 29570919
[TBL] [Abstract][Full Text] [Related]
20. Collapsing glomerulopathy is common in the setting of thrombotic microangiopathy of the native kidney.
Buob D; Decambron M; Gnemmi V; Frimat M; Hoffmann M; Azar R; Gheerbrant JD; Guincestre T; Noël C; Copin MC; Glowacki F
Kidney Int; 2016 Dec; 90(6):1321-1331. PubMed ID: 27650730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
